Bradford D. Dahms
2021 - Theseus Pharmaceuticals
In 2021, Bradford D. Dahms earned a total compensation of $1.9M as Chief Financial Officer at Theseus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $108,638 |
|---|---|
| Option Awards | $1,567,901 |
| Salary | $248,208 |
| Total | $1,924,747 |
Dahms received $1.6M in option awards, accounting for 81% of the total pay in 2021.
Dahms also received $108.6K in non-equity incentive plan and $248.2K in salary.
Rankings
In 2021, Bradford D. Dahms' compensation ranked 6,180th out of 12,415 executives tracked by ExecPay. In other words, Dahms earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,180 out of 12,415 | 50th |
Division Manufacturing | 2,619 out of 5,505 | 52nd |
Major group Chemicals And Allied Products | 1,142 out of 2,375 | 52nd |
Industry group Drugs | 1,016 out of 2,096 | 52nd |
Industry Pharmaceutical Preparations | 735 out of 1,546 | 53rd |
Source: SEC filing on April 25, 2022.
Dahms' colleagues
We found four more compensation records of executives who worked with Bradford D. Dahms at Theseus Pharmaceuticals in 2021.